Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of Invacare
So what: According to a company press release, the FDA has issued a consent decree relating to previously observed violations at Invacare's corporate headquarters and a wheelchair-manufacturing facility in Ohio. Regulators are seeking an injunction until the violations are addressed.
Now what: The news comes at an awful time for Invacare, which had been building a national network for renting equipment for long-term care. Now those plans may have to be put on hold. Do you agree? Would you buy shares of Invacare or any of its peers at current prices? Please weigh in using the comments box below.
Interested in more information about Invacare? Add it to your watchlist.
Fool contributor Tim Beyers is a member of the Motley Fool Rule Breakers stock-picking team. He didn't own shares in any of the companies mentioned at the time of publication. Check out Tim's portfolio holdings and Foolish writings, or connect with him on Google+ or Twitter, where he goes by @milehighfool. You can also get his insights delivered directly to your RSS reader.
Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.